The present invention concerns a method of therapeutic prevention and
treatment of a heart disease chosen from cardiac insufficiency and heart
failure including the administration of an essential fatty acid
containing a mixture of eicosapentaenoic acid ethyl ester (EPA) and
docosahexaenoic acid ethyl ester (DHA), either alone or in combination
with another therapeutic agent.